Related Experiment Video
Updated: Sep 6, 2025

Viability Assays for Cells in Culture
Published on: January 20, 2014
Differential vulnerability of anterior cingulate cortex cell types to diseases and drugs
Marissa A Smail1,2, Sapuni S Chandrasena3, Xiaolu Zhang4
1Department of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH, USA.
Abstract:
In psychiatric disorders, mismatches between disease states and therapeutic strategies are highly pronounced, largely because of unanswered questions regarding specific vulnerabilities of different cell types and therapeutic responses. Which cellular events (housekeeping or salient) are most affected? Which cell types succumb first to challenges, and which exhibit the strongest response to drugs? Are these events coordinated between cell types? How does disease and drug effect this coordination? To address these questions, we analyzed single-nucleus-RNAseq (sn-RNAseq) data from the human anterior cingulate cortex-a region involved in many psychiatric disorders. Density index, a metric for quantifying similarities and dissimilarities across functional profiles, was employed to identify common or salient functional themes across cell types. Cell-specific signatures were integrated with existing disease and drug-specific signatures to determine cell-type-specific vulnerabilities, druggabilities, and responsiveness. Clustering of functional profiles revealed cell types jointly participating in these events. SST and VIP interneurons were found to be most vulnerable, whereas pyramidal neurons were least. Overall, the disease state is superficial layer-centric, influences cell-specific salient themes, strongly impacts disinhibitory neurons, and influences astrocyte interaction with a subset of deep-layer pyramidal neurons. In absence of disease, drugs profiles largely recapitulate disease profiles, offering a possible explanation for drug side effects. However, in presence of disease, drug activities, are deep layer-centric and involve activating a distinct subset of deep-layer pyramidal neurons to circumvent the disease state's disinhibitory circuit malfunction. These findings demonstrate a novel application of sn-RNAseq data to explain drug and disease action at a systems level.
Insights
Psychiatric disorders reveal cell-type vulnerabilities and drug responses using single-nucleus RNA sequencing (sn-RNAseq). Findings explain how diseases and treatments impact neural circuits, guiding future therapeutic strategies.
Area of Science:
- Neuroscience
- Genomics
- Pharmacology
Background:
- Psychiatric disorders present significant challenges due to a lack of understanding regarding cell-type specific vulnerabilities and drug responses.
- Key questions remain about which cellular events are most affected, which cell types are most vulnerable, and how these are coordinated across cell types during disease and treatment.
Purpose of the Study:
- To analyze single-nucleus RNA sequencing (sn-RNAseq) data from the human anterior cingulate cortex to understand cell-type specific responses in psychiatric disorders.
- To identify cell-type vulnerabilities, druggabilities, and responsiveness by integrating functional profiles with disease and drug signatures.
Main Methods:
- Utilized single-nucleus RNA sequencing (sn-RNAseq) data from the human anterior cingulate cortex.
- Employed the density index metric to quantify similarities and dissimilarities across functional profiles.
- Integrated cell-specific signatures with existing disease and drug-specific signatures.
Main Results:
- Identified specific cell types, notably SST and VIP interneurons, as most vulnerable, while pyramidal neurons were least vulnerable.
- Revealed that the disease state is superficial layer-centric, affecting cell-specific themes and disinhibitory neurons.
- Demonstrated that in disease states, drug actions are deep layer-centric, activating specific pyramidal neurons to counteract circuit malfunctions.
Conclusions:
- Single-nucleus RNA sequencing (sn-RNAseq) offers a novel approach to understanding drug and disease mechanisms at a systems level.
- Findings illuminate the complex interplay between cell types in psychiatric disorders and their differential responses to therapeutic interventions.
- The study provides insights into potential mechanisms behind drug side effects and identifies targeted neuronal populations for therapeutic strategies.
More Related Videos
08:23Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line
Published on: August 9, 2014
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Related Concept Videos
Drugs Affecting Neurotransmitter Release or Uptake
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...